HealthFDA Approves Two New Alzheimer’s Blood Tests for Early Detection
The FDA has approved two new blood tests for Alzheimer’s disease, including one designed for adults as young as 40. These tests, which involve biomarkers like P-tau217 and genetic markers, aim to enable earlier diagnosis and prediction of Alzheimer’s symptoms years before onset. This advancement could improve early intervention and patient outcomes.
medicalnewstoday.com·1d ago




